Development and clinical application of a novel urinary cortisol extraction agent
- PMID: 40610812
- DOI: 10.1007/s00216-025-05998-7
Development and clinical application of a novel urinary cortisol extraction agent
Abstract
Dichloromethane (DCM), a traditional extractant for 24-h urine free cortisol (UFC) testing, poses significant occupational hazards. This study aimed to explore a novel extractant, evaluate its performance in replacing DCM, and establish the biological reference range for UFC detection using the new extractant. Comparative analyses of extraction efficiency were conducted between ethyl acetate (EA) and DCM. A stabilized EA-based formulation (named EEG) was developed by incorporating anhydrous ethanol and gallic acid as anti-hydrolysis and volatility-reducing agents. Recovery rates were assessed using a control product. Stability was tested through delayed detection. Biological reference intervals were determined via chemiluminescence immunoassay (CLIA) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) following EEG extraction, and determined the reference interval using mean ± 1.96 standard deviation. EA demonstrated superior extraction efficiency, yielding significantly higher median cortisol levels (6.27 (IQR 4.68-8.68) µg/dL) versus DCM (3.96 (IQR 2.41-5.07) µg/dL, p = 0.002). Recovery tests confirmed EA's enhanced performance (mean recovery 95.3% vs. DCM's 65.4%, p = 0.011). The EEG formulation exhibited improved stability with unchanged extraction efficacy. Established reference intervals (95% range) were 14.58~136.62 µg/24 h (CLIA) and 0.81~60.55 µg/24 h (LC-MS/MS). EA extraction surpasses DCM in recovery and safety. The optimized EEG formulation demonstrates enhanced stability while maintaining analytical reliability. The newly established reference intervals provide method-specific benchmarks for clinical UFC assessment. This innovation offers a safer, more efficient alternative for routine laboratory practice. The findings underscore the feasibility of replacing hazardous solvents in endocrine diagnostics without compromising analytical performance.
Keywords: Biological reference interval; Dichloromethane; Ethyl acetate; Extraction; Urinary free cortisol.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.
Conflict of interest statement
Declarations. Research ethics: Informed consent was obtained from all individuals included in this study, or their legal guardians or wards. This study was approved by the Medical Ethics Committee of Tianjin Medical University General Hospital: IRB2023-KY-244. Competing interests: The authors declare no competing interests.
Similar articles
-
Comparative evaluation of four new immunoassays and LC-MS/MS for the measurement of urinary free cortisol in Cushing's syndrome diagnosis.Pract Lab Med. 2025 Jun 11;46:e00484. doi: 10.1016/j.plabm.2025.e00484. eCollection 2025 Sep. Pract Lab Med. 2025. PMID: 40584217 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
A Study of Adrenal Incidentaloma-Related Hormonal Assays After First Integration of the Diagnosis Within Primary Healthcare.Diseases. 2025 May 26;13(6):169. doi: 10.3390/diseases13060169. Diseases. 2025. PMID: 40558580 Free PMC article.
-
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2. Cochrane Database Syst Rev. 2022. PMID: 35233774 Free PMC article.
References
-
- Jimeno B, Rubalcaba JG. Modelling the role of glucocorticoid receptor as mediator of endocrine responses to environmental challenge. Philos Trans R Soc Lond B Biol Sci. 2024;379(1898):20220501. https://doi.org/10.1098/rstb.2022.0501 . - DOI - PubMed - PMC
-
- Luo J, Zhou C, Wang S, Tao S, Liao Y, Shi Z, Tang Z, Wu Y, Liu Y, Yang P. Cortisol synergizing with endoplasmic reticulum stress induces regulatory T-cell dysfunction. Immunology. 2023;170(3):334–43. https://doi.org/10.1111/imm.13669 . - DOI - PubMed
-
- El-Farhan N, Rees DA, Evans C. Measuring cortisol in serum, urine and saliva - are our assays good enough? Ann Clin Biochem. 2017;54(3):308–22. https://doi.org/10.1177/0004563216687335 . - DOI - PubMed
-
- Choi MH. Clinical and technical aspects in free cortisol measurement. Endocrinol Metab (Seoul). 2022;37(4):599–607. https://doi.org/10.3803/EnM.2022.1549 . - DOI - PubMed
-
- Mu D, Fang J, Yu S, Ma Y, Cheng J, Hu Y, Song A, Zhao F, Zhang Q, Qi Z, Zhang K, Xia L, Qiu L, Zhu H, Cheng X. Comparison of direct and extraction immunoassay methods with liquid chromatography-tandem mass spectrometry measurement of urinary free cortisol for the diagnosis of Cushing’s syndrome. Ann Lab Med. 2024;44(1):29–37. https://doi.org/10.3343/alm.2024.44.1.29 . - DOI - PubMed
Grants and funding
- 82202536/National Natural Science Foundation of China
- 2023032/Entrusted Project by Enterprises and Tianjin Medical University General Hospital
- 25YFKFYS00940/Tianjin Health and Hygiene General Project
- 25YFKFYS00940/Tianjin Key R&D Program, Special Project for Research and Development of Science and Technology Service Industry
LinkOut - more resources
Full Text Sources